In the United States, $2.5 trillion is spent on healthcare annually. Seven chronic diseases account for half of all this expense. Of these 7, cardiovascular disease, hypertension, stroke, and diabetes mellitus are largely preventable. Integrative cardiology programs that focus on risk‐factor modification through lifestyle change combined with early detection and advanced lipid management offer a new paradigm to the prevention of cardiovascular disease.
OgdenCLCarrollMDCurtinLRMcDowellMATabakCJFlegalKM. Prevalence of overweight and obesity in the United States, 1999‐2004. JAMA. 2006;295:1549‐1555.
2.
NarayanKMBoyleJPThompsonTJSorensenSWWilliamsonDF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884‐1890.
3.
MoscaLLinfanteAHBenjaminEJ. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499‐510.
4.
VogelJHKKrucoffMW, eds. Integrative Cardiology: Complementary and Alternative Medicine for the Heart. New York: McGraw‐Hill; 2007.
5.
MokdadAHMarksJSStroupDFGerberdingJL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238‐1245.
6.
TuomilehtoJLindstromJErikssonJG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343‐1350.
7.
VogelRACorrettiMCPlotnickGD. Effect of a single high‐fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350‐354.
8.
CampbellTCParpiaBChenJ. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study. Am J Cardiol. 1998;82:18‐21.
9.
ChenJCampbellTCLiJPetoR, Diet, Lifestyle and Mortality in China. Oxford, UK: Oxford University Press; 1990.
10.
EckelRHKraussRM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998;97:2099‐2100.
11.
AscherioA. Epidemiologic studies on dietary fats and coronary heart disease. Am J Med. 2002;113(suppl 9B)9S‐12S.
12.
HuFBStampferMJMansonJE. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491‐1499.
13.
de LorgerilMSalenPMartinJLMonjaudIDelayeJMamelleN. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779‐785.
14.
SinghRBDubnovGNiazMA. Effect of an Indo‐Mediterranean diet on progression of coronary artery disease in high risk patients (Indo‐Mediterranean Diet Heart Study): a randomised single‐blind trial. Lancet. 2002;360:1455‐1461.
15.
HuFBWillettWC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569‐2578.
16.
TanasescuMLeitzmannMFRimmEBWillettWCStampferMJHuFB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994‐2000.
17.
TaylorRSBrownAEbrahimS. Exercise‐based rehabilitation for patients with coronary heart disease: systematic review and meta‐analysis of randomized controlled trials. Am J Med. 2004;116:682‐692.
18.
HambrechtRWaltherCMobius‐WinklerS. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109:1371‐1378.
19.
BodenWEO’RourkeRATeoKK. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503‐1516.
20.
MittlemanMAMaclureMSherwoodJB. Triggering of acute myocardial infarction onset by episodes of anger. Circulation. 1995;92:1720‐1725.
21.
Frasure‐SmithNLesperanceFTalajicM. Depression and 18‐month prognosis after myocardial infarction. Circulation. 1995;91:999‐1005.
22.
ZiegelsteinRCFauerbachJAStevensSSRomanelliJRichterDPBushDE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818‐1823.
23.
LesperanceFFrasure‐SmithNJuneauMTherouxP. Depression and 1‐year prognosis in unstable angina. Arch Intern Med. 2000;160:1354‐1360.
24.
BlumenthalJASherwoodABabyakMA. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293:1626‐1634.
25.
SchneiderRHAlexanderCNStaggersF. Long‐term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension. Am J Cardiol. 2005;95:1060‐1064.
26.
DusseldorpEvan ElderenTMaesSMeulmanJKraaijV. A meta‐analysis of psychoeducational programs for coronary heart disease patients. Health Psychol. 1999;18:506‐519.
27.
Paul‐LabradorMPolkDDwyerJH. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218‐1224.
28.
GrossmanPNiemannLSchmidtSWalachH. Mindfulness‐based stress reduction and health benefits: a meta‐analysis. J Psychosom Res. 2004;57:35‐43.
29.
CarlsonLESpecaMPatelKDGoodeyE. Mindfulness‐based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448‐474.
30.
TaconAMMcCombJCalderaYRandolphP. Mindfulness meditation, anxiety reduction, and heart disease: a pilot study. Fam Community Health. 2003;26:25‐33.
31.
Robert‐McCombJJTaconARandolphPCalderaY. A pilot study to examine the effects of a mindfulness‐based stress‐reduction and relaxation program on levels of stress hormones, physical functioning, and submaximal exercise responses. J Altern Complement Med. 2004;10:819‐827.
32.
SiegelJM. Stressful life events and use of physician services among the elderly: the moderating role of pet ownership. J Pers Soc Psychol. 1990;58:1081‐1086.
33.
HeadeyB. Health benefits and health cost savings due to pets: preliminary results from an Australian national survey. Soc Indicators Res. 1999;47:233‐243.
34.
AndersonWPReidCMJenningsGL. Pet ownership and risk factors for cardiovascular disease. Med J Aust. 1992;157:298‐301.
35.
FriedmannEThomasSASteinPKKleigerRE. Relation between pet ownership and heart rate variability in patients with healed myocardial infarcts. Am J Cardiol. 2003;91:718‐721.
36.
KshettryVRCaroleLFHenlySJSendelbachSKummerB. Complementary alternative medical therapies for heart surgery patients: feasibility, safety, and impact. Ann Thorac Surg. 2006;81:201‐205.
37.
GayMC. Effectiveness of hypnosis in reducing mild essential hypertension: a one‐year follow‐up. Int J Clin Exp Hypn. 2007;55:67‐83.
38.
HippelCVHoleGKaschkaWP. Autonomic profile under hypnosis as assessed by heart rate variability and spectral analysis. Pharmacopsychiatry. 2001;34:111‐113.
39.
LehrerPMVaschilloEVaschilloB. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback. 2000;25:177‐191.
40.
NakaoMNomuraSShimosawaT. Clinical effects of blood pressure biofeedback treatment on hypertension by auto‐shaping. Psychosom Med. 1997;59:331‐338.
KleigerREMillerJPBiggerJTJrMossAJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256‐262.
43.
BiggerJTFleissJLRolnitzkyLMSteinmanRC. The ability of several short‐term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927‐934.
44.
Del PozoJMGevirtzRNScherBGuarneriE. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147:E11.
45.
YehGYWoodMJLorellBH. Effects of tai chi mind‐body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med. 2004;117:541‐548.
